ID: ALA5192239

Max Phase: Preclinical

Molecular Formula: C28H43NO8

Molecular Weight: 521.65

Associated Items:

Representations

Canonical SMILES:  CC(=O)O[C@@H](C)/C=C\C(=O)N[C@@H]1C[C@H](C)[C@H](C/C=C(C)/C=C/[C@H]2O[C@H](CCO)C[C@@]3(CO3)[C@@H]2O)O[C@@H]1C

Standard InChI:  InChI=1S/C28H43NO8/c1-17(7-10-25-27(33)28(16-34-28)15-22(37-25)12-13-30)6-9-24-18(2)14-23(20(4)36-24)29-26(32)11-8-19(3)35-21(5)31/h6-8,10-11,18-20,22-25,27,30,33H,9,12-16H2,1-5H3,(H,29,32)/b10-7+,11-8-,17-6+/t18-,19-,20+,22+,23+,24-,25+,27+,28+/m0/s1

Standard InChI Key:  HRGJGQOKVJIBSP-DNJPMNNJSA-N

Associated Targets(Human)

MES-SA/Dx5 643 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MES-SA 905 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HEK-293T 167025 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 521.65Molecular Weight (Monoisotopic): 521.2989AlogP: 2.35#Rotatable Bonds: 10
Polar Surface Area: 126.85Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.92CX Basic pKa: CX LogP: 1.23CX LogD: 1.23
Aromatic Rings: 0Heavy Atoms: 37QED Weighted: 0.17Np Likeness Score: 2.58

References

1. Ghosh AK, Mishevich JL, Jurica MS..  (2021)  Spliceostatins and Derivatives: Chemical Syntheses and Biological Properties of Potent Splicing Inhibitors.,  84  (5.0): [PMID:33974423] [10.1021/acs.jnatprod.1c00100]

Source